NOSQUEST is an affiliated company of ASTA(listed on KOSDAQ) that has successfully developed MALDI-TOF(Matrix-Assisted Laser Desorption Ionization – Time of Flight) mass spectrometer. NOSQUEST has developed the country's first MALDI-TOF-based integrated diagnostic system. We provide the qualified diagnostic service with low cost and rapid resulting in early prediction and treatment for common diseases, cancer, and degenerative brain diseases.
NOSQUEST is a team of highly motivated people consisting of Ph.D. researchers (approx. 20% out of total) and has researched more than ten years in this field funded by the Korean government.
The MALDI-TOF diagnostic system is globally considered as high value-added technology. In this regard, our advantages would be enhanced price competitiveness and better miniaturization technique compared to competitors.